Educational tool-kit on diet and exercise: survey of prostate cancer patients about to receive androgen deprivation therapy.
OBJECTIVE
To test a tool-kit designed to improve well-being in patients with prostate cancer. Lifestyle changes might lessen the metabolic, cardiovascular, and osseous side effects of androgen deprivation therapy (ADT) in prostate cancer patients.


METHODS
Urologists supplied 10 consecutive patients initiating ADT with a tool-kit (information brochure, practical guidance on diet and exercise, recipe booklet, and lifestyle diary). The urologists completed a total 4 questionnaires, at study initiation, one at the patients' first and second visits, and one at study completion.


RESULTS
Overall, 91 urologists completed all questionnaires; 585 patients (median age, 75 years) were seen at the first visit, and 511 patients at the second. Patient response rate to the first questionnaire was 62% and 56% to the second. After the first visit, 82% of respondents reported being very glad or glad to receive the kit; among those having read the practical guidance (301/362), 57% had started implementation and 36% intended to do so. After the second visit, 76% were satisfied with the tool-kit and 84% were implementing guidance. Clinician satisfaction rate was 82%: benefits were improved patient dialogue (62%), follow-up (55%), and better explanation of side effects (51%). Only 14 clinicians were not pleased by the tool kit. Their main criticisms (too long, tedious, not tailored to individual needs) matched those of patients.


CONCLUSIONS
Written detailed guidance on diet and physical exercise for patients about to receive ADT met a genuine need and was well perceived by both clinicians and patients. Implementation rate was high. However, content should be adapted to patient age and disease stage.
Urology and Renal Transplantation Department, FOCH Hospital, University of Versailles Saint-Quentin-en-Yvelines, Suresnes, France. t.lebret@hopital-foch.org
Thierry
T
Lebret
Patrick
P
Coloby
Jean Luc
JL
Descotes
Stéphane
S
Droupy
Marc
M
Geraud
Bertrand
B
Tombal
D000230:Adenocarcinoma / Q000188:drug therapy*; D000728:Androgens; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001291:Attitude of Health Personnel; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000517:prevention & control; D055927:Cookbooks as Topic; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced / Q000517:prevention & control; D004032:Diet; D015444:Exercise; D005602:France; D006727:Hormone Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008019:Life Style; D008137:Longitudinal Studies; D008297:Male; D008499:Medical Records; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D009765:Obesity / Q000139:chemically induced / Q000517:prevention & control; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control; D010174:Pamphlets; D010342:Patient Acceptance of Health Care; D010353:Patient Education as Topic; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011795:Surveys and Questionnaires; D014572:Urology
D000728:Androgens; D018931:Antineoplastic Agents, Hormonal; D006727:Hormone Antagonists